Health Catalyst, Inc. (HCAT)
NASDAQ: HCAT · Real-Time Price · USD
3.065
-0.155 (-4.81%)
Aug 14, 2025, 11:33 AM - Market open
Health Catalyst Stock Forecast
Stock Price Forecast
The 11 analysts that cover Health Catalyst stock have a consensus rating of "Buy" and an average price target of $6.18, which forecasts a 101.63% increase in the stock price over the next year. The lowest target is $3.50 and the highest is $13.
Price Target: $6.18 (+101.63%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Health Catalyst stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Buy | 6 | 5 | 5 | 5 | 5 | 4 |
| Hold | 3 | 4 | 4 | 4 | 4 | 6 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 11 | 11 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy Maintains $10 → $6 | Buy | Maintains | $10 → $6 | +95.76% | Aug 11, 2025 |
| Citigroup | Citigroup | Strong Buy → Hold Downgrades $6.5 → $3.5 | Strong Buy → Hold | Downgrades | $6.5 → $3.5 | +14.19% | Aug 8, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy → Hold Downgrades $9 → $4 | Buy → Hold | Downgrades | $9 → $4 | +30.51% | Aug 8, 2025 |
| Stifel | Stifel | Hold Maintains $5.5 → $4.5 | Hold | Maintains | $5.5 → $4.5 | +46.82% | Aug 8, 2025 |
| Evercore ISI Group | Evercore ISI Group | Hold Maintains $5 → $4 | Hold | Maintains | $5 → $4 | +30.51% | Jul 9, 2025 |
Financial Forecast
Revenue This Year
340.96M
from 306.58M
Increased by 11.21%
Revenue Next Year
372.07M
from 340.96M
Increased by 9.12%
EPS This Year
0.24
from -1.15
EPS Next Year
0.38
from 0.24
Increased by 57.59%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 351.9M | 388.6M | 436.6M | |
| Avg | 341.0M | 372.1M | 410.4M | |
| Low | 326.1M | 345.6M | 378.8M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 14.8% | 14.0% | 17.3% | |
| Avg | 11.2% | 9.1% | 10.3% | |
| Low | 6.4% | 1.3% | 1.8% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 0.40 | 0.50 | 0.80 | |
| Avg | 0.24 | 0.38 | 0.65 | |
| Low | 0.16 | 0.28 | 0.52 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | - | 106.7% | 107.7% | |
| Avg | - | 57.6% | 67.9% | |
| Low | - | 16.6% | 35.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.